UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis

Molecules (Basel, Switzerland), 2020-09, Vol.25 (17), p.4002

2020

Volltextzugriff (PDF)

Development of an in vitro media perfusion model of Leishmania major macrophage infection

PloS one, 2019-07, Vol.14 (7), p.e0219985-e0219985

2019

Volltextzugriff (PDF)

In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs

Antimicrobial Agents and Chemotherapy, 2006-01, Vol.50 (1), p.73-79

2006

Volltextzugriff (PDF)

Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model

Journal of pharmacy and pharmacology, 2016-07, Vol.68 (7), p.862-872

2016

Volltextzugriff (PDF)

Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase

PLoS neglected tropical diseases, 2013-11, Vol.7 (11), p.e2571

2013

Volltextzugriff (PDF)

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

International journal for parasitology -- drugs and drug resistance, 2019-12, Vol.11, p.129-138

2019

Volltextzugriff (PDF)

Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India

PLoS neglected tropical diseases, 2021-02, Vol.15 (2), p.e0009129-e0009129

2021

Volltextzugriff (PDF)

Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.5356-5358

2010

Volltextzugriff (PDF)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis

PLoS neglected tropical diseases, 2021-03, Vol.15 (3), p.e0009013

2021

Volltextzugriff (PDF)

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial

Molecules (Basel, Switzerland), 2017-12, Vol.22 (12), p.2102

2017

Volltextzugriff (PDF)

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis

International journal for parasitology -- drugs and drug resistance, 2018-08, Vol.8 (2), p.223-228

2018

Volltextzugriff (PDF)

Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug

PLoS neglected tropical diseases, 2021-04, Vol.15 (4), p.e0009276

2021

Volltextzugriff (PDF)

Artemisone-A Highly Active Antimalarial Drug of the Artemisinin Class

Angewandte Chemie (International ed.), 2006-03, Vol.45 (13), p.2082-2088

2006

Volltextzugriff (PDF)

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis

Pharmaceutics, 2021-04, Vol.13 (4), p.516

2021

Volltextzugriff (PDF)

Structure-activity relationships of antileishmanial and antimalarial chalcones

Bioorganic & medicinal chemistry, 2003-07, Vol.11 (13), p.2729-2738

2003

Volltextzugriff (PDF)

Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs

Microorganisms (Basel), 2020-06, Vol.8 (6), p.831

2020

Volltextzugriff (PDF)

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis

Wellcome open research, 2019-01, Vol.3, p.135

2019

Volltextzugriff (PDF)

Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India

PLOS global public health, 2022, Vol.2 (11), p.e0001049

2022

Volltextzugriff (PDF)

Leishmania and other intracellular pathogens: selectivity, drug distribution and PK–PD: BSP Autumn Symposium “Microbial protein targets: towards understanding and intervention”, 14th–16th September 2016, University of Durham UK

Parasitology, 2018-02, Vol.145 (2), p.237-247

CROFT, SIMON L.

2018

Volltextzugriff (PDF)

Drug permeation and barrier damage in Leishmania-infected mouse skin

Journal of antimicrobial chemotherapy, 2016-06, Vol.71 (6), p.1578-1585

2016

Volltextzugriff (PDF)

Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria

Natural product reports, 2021-12, Vol.38 (12), p.2214-2235

2021

Volltextzugriff (PDF)

Activity of anti-cancer protein kinase inhibitors against Leishmania spp

Journal of antimicrobial chemotherapy, 2014-07, Vol.69 (7), p.1888-1891

2014

Volltextzugriff (PDF)

Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis

Antimicrobial agents and chemotherapy, 2018-03, Vol.62 (3)

2018

Volltextzugriff (PDF)

Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(188)

Publikationsform

Artikel
(188)
Buchkapitel
(7)

Sprache

Englisch
(191)
Deutsch
(4)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(108)
Animals
(88)
Pharmacology & Pharmacy
(72)
Biological And Medical Sciences
(62)
Medical Sciences
(59)
Pharmacology. Drug Treatments
(56)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(47)
Antiparasitic Agents
(43)
Mice
(43)
Chemistry, Medicinal
(37)
Antiprotozoal Agents - Pharmacology
(35)
Physical Sciences
(34)
Leishmania Donovani - Drug Effects
(33)
Microbiology
(30)
Chemistry
(27)
Mice, Inbred Balb C
(27)
Female
(25)
Plasmodium Falciparum - Drug Effects
(24)
Infectious Diseases
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis

Development of an in vitro media perfusion model of Leishmania major macrophage infection

In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs

Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model

Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India

Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis

Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug

Artemisone-A Highly Active Antimalarial Drug of the Artemisinin Class

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis

Structure-activity relationships of antileishmanial and antimalarial chalcones

Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis

Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India

Leishmania and other intracellular pathogens: selectivity, drug distribution and PK–PD: BSP Autumn Symposium “Microbial protein targets: towards understanding and intervention”, 14th–16th September 2016, University of Durham UK

Drug permeation and barrier damage in Leishmania-infected mouse skin

Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis

Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria

Activity of anti-cancer protein kinase inhibitors against Leishmania spp

Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis

Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis

Aktive Filter

Suchergebnisse filtern